Supplement
Organosulfur compounds (allicin, S-allylcysteine) inhibit cholesterol synthesis, provide vasodilation via H₂S/NO pathways, antimicrobial activity, and immunomodulation.[1322,1324,1365, etc.]
Superscript reference numbers link to the Sources bibliography.
Composite Rating
Blends evidence depth, community direction, safety friction, and completeness.
Evidence Intensity
100/100
High depth from human/RCT/meta counts
Community Direction
1
Mixed / Neutral • confidence Minimal
Safety Friction
100/100
High signal from adverse/interaction markers
Data Completeness
100%
Studies 24 • mentions 9 • links 113
Not medical advice. This product is for educational and informational purposes only. It does not diagnose, treat, cure, or prevent any disease and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.
FDA disclaimer: These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Results may vary. Not intended for use by pregnant or nursing women, individuals under 18, or those with known medical conditions without physician consultation.
If you are experiencing a medical emergency, call 911 or your local emergency number immediately.
Goal alignment: Heart Health, Immune Support, Inflammation, Blood Sugar.[506,654,878, etc.]
Dose guide: Human-study daily dose: 1 mg-250 mg/day (higher-confidence extraction from PubMed abstracts)..[506,654,878, etc.]
Category
Botanical
Evidence Tier
ROBUST
Daily Guide
Human-study daily dose: 1 mg-250 mg/day (higher-confidence extraction from PubMed abstracts).
Clinical Depth
Humans: 100 • RCTs: 39 • Meta: 5
Cohort / Real-World
Cohort signals: 0
Safety Markers
Adverse signals: 150 • Interactions: 60
Freshness, trend, and study timeline for this item
Status
Trend
→ Stable evidence base
Depth
219 total studies · 8 recent
Timeline
Animal-only studies
402
In vitro / tissue
244
Total indexed
219
Safety adverse signals
150
Human studies
100
Interaction signals
60
Weighted direction score: 1 (Mixed / Neutral)
≥2 meta-analyses OR (≥5 RCTs AND ≥25 human studies).
Animal-only studies
402
In vitro / tissue
244
Total indexed
219
Safety adverse signals
150
Human studies
100
Interaction signals
60
Randomized trials
39
Meta-analyses
5
Distribution of evidence by study design strength
Evidence Strength: High
Composite of study volume, RCTs, and meta-analyses
PMID 29576354 • 2018 Apr
Aged garlic extract supplementation modifies inflammation and immunity of adults with obesity: A randomized, double-blind, placebo-controlled clinical trial.
Clinical nutrition ESPEN
Open PubMedPMID 26954484 • 2016 May-Jun
The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial.
Journal of diabetes and its complications
Open PubMedPMID 27743130 • 2017 Aug
Efficacy and safety of fermented garlic extract on hepatic function in adults with elevated serum gamma-glutamyl transpeptidase levels: a double-blind, randomized, placebo-controlled trial.
European journal of nutrition
Open PubMedPMID 22280901 • 2012 Jun
Supplementation with aged garlic extract improves both NK and γδ-T cell function and reduces the severity of cold and flu symptoms: a randomized, double-blind, placebo-controlled nutrition intervention.
Clinical nutrition (Edinburgh, Scotland)
Open PubMedPMID 8942410 • 1996 Dec
A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids.
The American journal of clinical nutrition
Open PubMedPMID 32673835 • 2020 Sep-Oct
Effects of garlic supplementation on serum inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.
Diabetes & metabolic syndrome
Open PubMedPMID 32349742 • 2020 Apr 29
The effect of aged garlic extract on the atherosclerotic process - a randomized double-blind placebo-controlled trial.
BMC complementary medicine and therapies
Open PubMedPMID 15726891 • 2004 Dec
Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study.
Hiroshima journal of medical sciences
Open PubMedPMID 29604599 • 2018 Jun
Garlic extract favorably modifies markers of endothelial function in obese patients -randomized double blind placebo-controlled nutritional intervention.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Open PubMedPMID 39437887 • 2024 Dec
Effects of aged garlic extract on blood pressure in hypertensive patients: A systematic review and meta-analysis of randomized controlled trials.
Prostaglandins & other lipid mediators
Open PubMedPMID 36640154 • 2023 Jun
Effect of garlic extract on markers of lipid metabolism and inflammation in coronary artery disease (CAD) patients: A systematic review and meta-analysis.
Phytotherapy research : PTR
Open PubMedPMID 8582091 • 1995 Jun-Jul
Effects of garlic extract on platelet aggregation: a randomized placebo-controlled double-blind study.
Clinical and experimental pharmacology & physiology
Open PubMedPMID 34627133 • 2021 Dec
Effects of garlic extract on lipid profile in patients with coronary artery disease: A systematic review and meta-analysis of randomised clinical trials.
International journal of clinical practice
Open PubMedPMID 26852373 • 2017 Jan
Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses.
British journal of clinical pharmacology
Open PubMedPMID 17885009 • 2007 Oct
Does garlic reduce risk of colorectal cancer? A systematic review.
The Journal of nutrition
Open PubMedPMID 35276764 • 2022 Jan 18
Effects of an Optimized Aged Garlic Extract on Cardiovascular Disease Risk Factors in Moderate Hypercholesterolemic Subjects: A Randomized, Crossover, Double-Blind, Sustainedand Controlled Study.
Nutrients
Open PubMedPMID 39001718 • 2024 Dec 1
Randomized, double-blind clinical trial evaluating the impact of freeze-dried garlic extract capsules on blood pressure, lipid profile, and nitric oxide levels in individuals at risk for hypertension.
Hormone molecular biology and clinical investigation
Open PubMedPMID 31511230 • 2019 Sep 11
Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial.
BMJ (Clinical research ed.)
Open PubMedPMID 16849680 • 2006 Jul 19
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
Journal of the National Cancer Institute
Open PubMedPMID 29140808 • 2018 Jun
Randomized trial evaluating the effect of aged garlic extract with supplements versus placebo on adipose tissue surrogates for coronary atherosclerosis progression.
Coronary artery disease
Open PubMedPMID 35505122 • 2022 Oct
Improved microvascular reactivity after aged garlic extract intake is not mediated by hydrogen sulfide in older adults at risk for cardiovascular disease: a randomized clinical trial.
European journal of nutrition
Open PubMedPMID 26764332 • 2016 Feb
Aged Garlic Extract Modifies Human Immunity.
The Journal of nutrition
Open PubMedPMID 26423732 • 2015 Nov
A Single Meal Containing Raw, Crushed Garlic Influences Expression of Immunity- and Cancer-Related Genes in Whole Blood of Humans.
The Journal of nutrition
Open PubMedPMID 37686723 • 2023 Aug 23
Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial.
Nutrients
Open PubMedBenefit reports: 4
Adverse reports: 3
No-effect reports: 1
Mixed reports: 1
Unclear reports: 0
Signal confidence: 0.00
Benefits
Adverse
No Effect
Aged garlic extract (Kyolic) is the best-studied form. Food-based garlic adds synergistic benefits. | Step2: Insufficient empirical signal for a directional adjustment.
Reddit evidence: 0 mentions (confidence 0.00).
Amazon signal: 0 products scanned (confidence 0.00).
GNC signal: 0 products scanned (confidence 0.00) [BLOCKED].
PerimeterX / captcha block encountered.
Search fetch failed: Failed to fetch after retries: https://old.reddit.com/search.json?raw_json=1&sort=relevance&t=year&limit=12&q=%22garlic%20extract%22%20(supplement%20OR%20dosage%20OR%20stack%20OR%20side%20effects%20OR%20review)%20(subreddit%3ASupplements%20OR%20subreddit%3ANootropics%20OR%20subreddit%3ABiohackers%20OR%20subreddit%3Alongevity%20OR%20subreddit%3ANutrition%20OR%20subreddit%3AHubermanLab%20OR%20subreddit%3ASleep%20OR%20subreddit%3AFitness%20OR%20subreddit%3Aketoscience%20OR%20subreddit%3AStackAdvice)
Fallback search failed: Failed to fetch after retries: https://old.reddit.com/search.json?raw_json=1&sort=comments&t=all&limit=16&q=%22garlic%20extract%22%20(supplement%20OR%20capsule%20OR%20powder%20OR%20experience%20OR%20results%20OR%20side%20effects)
Broad search failed: Failed to fetch after retries: https://old.reddit.com/search.json?raw_json=1&sort=new&t=all&limit=16&q=garlic%20extract
Use adverse/interactions PubMed signal counts for screening; perform clinician review before high-dose or multi-drug stack use.
Human-study daily dose signal: 1 mg-250 mg/day (confidence HIGH).
Extracted from 4 dosing mentions across 3 PubMed studies (mg/day).
Imported legacy community score: 7.0/10 (heuristic mapping confidence 1.00).
Legacy community note: Respected NAD+ precursor with strong safety data. Some community members prefer NMN for potency. Niagen brand has loyal following. Less "exciting" than NMN marketing-wise but solid science.
Sentiment Score
0.24/100
Benefit Mentions
Adverse Mentions
Best Responders
No responder profile recorded.
aggregate • benefit
Aggregate community signal: 9 directional mentions (benefit 4, adverse 3, no-effect 1, mixed 1).
Open mentionamazon
Amazon search for Aged Garlic Extract (Allicin)
Rating: n/a | Reviews: n/a
Open productEvidence Sources
Community Sources
META_ANALYSIS • 2015 • Adults
20 RCTs with 970 hypertensive subjects.
Outcome: Garlic significantly reduced SBP by −8.3 mmHg and DBP by −5.5 mmHg in hypertensives; Kyolic aged extract most studied.[1322,1324,1365, etc.]
Open sourceMETA_ANALYSIS • 2013 • Adults
39 RCTs with 2298 subjects.
Outcome: Garlic reduced total cholesterol by −17 mg/dL (−8%) and LDL by −9 mg/dL after 2+ months of supplementation.[1322,1324,1365, etc.]
Open sourceMETA_ANALYSIS • 2014 • Adults
8 studies with 735 subjects.
Outcome: Daily garlic supplementation reduced cold incidence (RR 0.56) but evidence quality was moderate; consistent immune modulation signal.[1322,1324,1365, etc.]
Open sourcePUBMED • Humans + preclinical triage
Counts aggregated from automated literature sweep and tiering rules.
Outcome: Tier HIGH; humans 100, RCTs 39, meta-analyses 5.[1322,1324,1365, etc.]
Open sourcePUBMED • 2018 • Human evidence curation set
PMID 29576354 from Clinical nutrition ESPEN.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2016 • Human evidence curation set
PMID 26954484 from Journal of diabetes and its complications.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2017 • Human evidence curation set
PMID 27743130 from European journal of nutrition.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2012 • Human evidence curation set
PMID 22280901 from Clinical nutrition (Edinburgh, Scotland).
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 1996 • Human evidence curation set
PMID 8942410 from The American journal of clinical nutrition.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2020 • Human evidence curation set
PMID 32673835 from Diabetes & metabolic syndrome.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2020 • Human evidence curation set
PMID 32349742 from BMC complementary medicine and therapies.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2004 • Human evidence curation set
PMID 15726891 from Hiroshima journal of medical sciences.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2018 • Human evidence curation set
PMID 29604599 from Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2024 • Human evidence curation set
PMID 39437887 from Prostaglandins & other lipid mediators.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2023 • Human evidence curation set
PMID 36640154 from Phytotherapy research : PTR.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 1995 • Human evidence curation set
PMID 8582091 from Clinical and experimental pharmacology & physiology.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2021 • Human evidence curation set
PMID 34627133 from International journal of clinical practice.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2017 • Human evidence curation set
PMID 26852373 from British journal of clinical pharmacology.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2007 • Human evidence curation set
PMID 17885009 from The Journal of nutrition.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2022 • Human evidence curation set
PMID 35276764 from Nutrients.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2024 • Human evidence curation set
PMID 39001718 from Hormone molecular biology and clinical investigation.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2019 • Human evidence curation set
PMID 31511230 from BMJ (Clinical research ed.).
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2006 • Human evidence curation set
PMID 16849680 from Journal of the National Cancer Institute.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2018 • Human evidence curation set
PMID 29140808 from Coronary artery disease.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2022 • Human evidence curation set
PMID 35505122 from European journal of nutrition.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2016 • Human evidence curation set
PMID 26764332 from The Journal of nutrition.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2015 • Human evidence curation set
PMID 26423732 from The Journal of nutrition.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourcePUBMED • 2023 • Human evidence curation set
PMID 37686723 from Nutrients.
Outcome: See linked PubMed abstract for methods and outcomes.[1322,1324,1365, etc.]
Open sourceRCT • 2024 • PubMed indexed study
PMID 39203947 from Nutrients.
Outcome: Study design: RCT. Quality score: 8.1/10.[1322,1324,1365, etc.]
Open sourceRCT • 2013 • PubMed indexed study
PMID 23169470 from European journal of clinical nutrition.
Outcome: Study design: RCT. Quality score: 8.1/10.[1322,1324,1365, etc.]
Open sourceRCT • 2006 • PubMed indexed study
PMID 16484573 from The Journal of nutrition.
Outcome: Study design: RCT. Quality score: 8.1/10.[1322,1324,1365, etc.]
Open sourceRCT • 2006 • PubMed indexed study
PMID 16484572 from The Journal of nutrition.
Outcome: Study design: RCT. Quality score: 8.1/10.[1322,1324,1365, etc.]
Open sourceRCT • 2006 • PubMed indexed study
PMID 16484565 from The Journal of nutrition.
Outcome: Study design: RCT. Quality score: 8.1/10.[1322,1324,1365, etc.]
Open sourceRCT • 2006 • PubMed indexed study
PMID 17023720 from The American journal of clinical nutrition.
Outcome: Study design: RCT. Quality score: 8.1/10.[1322,1324,1365, etc.]
Open sourceRCT • 2001 • PubMed indexed study
PMID 11238801 from The Journal of nutrition.
Outcome: Study design: RCT. Quality score: 8.1/10.[1322,1324,1365, etc.]
Open sourceRCT • 2018 • PubMed indexed study
PMID 29937536 from Nutrients.
Outcome: Study design: RCT. Quality score: 7.9/10.[1322,1324,1365, etc.]
Open sourceRCT • 2023 • PubMed indexed study
PMID 37170623 from Journal of the International Society of Sports Nutrition.
Outcome: Study design: RCT. Quality score: 7.8/10.[1322,1324,1365, etc.]
Open sourceRCT • 2024 • PubMed indexed study
PMID 38576169 from Journal of the International Society of Sports Nutrition.
Outcome: Study design: RCT. Quality score: 7.8/10.[1322,1324,1365, etc.]
Open sourceRCT • 2003 • PubMed indexed study
PMID 12948274 from Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 2013 • PubMed indexed study
PMID 23453866 from International journal of cardiology.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 1999 • PubMed indexed study
PMID 10217370 from Atherosclerosis.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 2012 • PubMed indexed study
PMID 22271764 from Journal of the National Cancer Institute.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 2009 • PubMed indexed study
PMID 19573556 from Preventive medicine.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 2007 • PubMed indexed study
PMID 17325296 from Archives of internal medicine.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 2005 • PubMed indexed study
PMID 16041725 from Phytotherapy research : PTR.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 1998 • PubMed indexed study
PMID 9641475 from Journal of cardiovascular pharmacology.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 2003 • PubMed indexed study
PMID 12580992 from British journal of clinical pharmacology.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 1998 • PubMed indexed study
PMID 9683311 from Controlled clinical trials.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 2010 • PubMed indexed study
PMID 20152239 from The American journal of cardiology.
Outcome: Study design: RCT. Quality score: 7.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 2000 • PubMed indexed study
PMID 11053504 from The Journal of nutrition.
Outcome: Study design: CONTROLLED_TRIAL. Quality score: 7.1/10.[1322,1324,1365, etc.]
Open sourceRCT • 2006 • PubMed indexed study
PMID 16484571 from The Journal of nutrition.
Outcome: Study design: CONTROLLED_TRIAL. Quality score: 7.1/10.[1322,1324,1365, etc.]
Open sourceRCT • 2003 • PubMed indexed study
PMID 12891227 from Clinical pharmacology and therapeutics.
Outcome: Study design: CONTROLLED_TRIAL. Quality score: 6.5/10.[1322,1324,1365, etc.]
Open sourceRCT • 2000 • PubMed indexed study
PMID 10793299 from Nutrition (Burbank, Los Angeles County, Calif.).
Outcome: Study design: CONTROLLED_TRIAL. Quality score: 6.5/10.[1322,1324,1365, etc.]
Open sourceCOHORT • 2016 • PubMed indexed study
PMID 27483310 from Nutrients.
Outcome: Study design: COHORT. Quality score: 5.9/10.[1322,1324,1365, etc.]
Open sourceCOHORT • 2024 • PubMed indexed study
PMID 39563466 from Journal of health, population, and nutrition.
Outcome: Study design: COHORT. Quality score: 5.8/10.[1322,1324,1365, etc.]
Open sourceCOHORT • 2022 • PubMed indexed study
PMID 35596542 from Inquiry : a journal of medical care organization, provision and financing.
Outcome: Study design: COHORT. Quality score: 5.7/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2009 • PubMed indexed study
PMID 19484634 from Critical reviews in food science and nutrition.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.5/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2025 • PubMed indexed study
PMID 40004239 from International journal of molecular sciences.
Outcome: Study design: OTHER. Quality score: 5.3/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2024 • PubMed indexed study
PMID 39097898 from Cellular and molecular biology (Noisy-le-Grand, France).
Outcome: Study design: OTHER. Quality score: 5.3/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2016 • PubMed indexed study
PMID 26764327 from The Journal of nutrition.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.2/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2015 • PubMed indexed study
PMID 25788027 from High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.2/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2001 • PubMed indexed study
PMID 11238796 from The Journal of nutrition.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.1/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2001 • PubMed indexed study
PMID 11238803 from The Journal of nutrition.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.1/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2013 • PubMed indexed study
PMID 23430658 from Current hypertension reports.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.1/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2001 • PubMed indexed study
PMID 11238800 from The Journal of nutrition.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.1/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2001 • PubMed indexed study
PMID 11238826 from The Journal of nutrition.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.1/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2020 • PubMed indexed study
PMID 32824835 from Nutrients.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.0/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2019 • PubMed indexed study
PMID 30704623 from Chinese journal of natural medicines.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.7/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2020 • PubMed indexed study
PMID 32651325 from Journal of Alzheimer's disease : JAD.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.7/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2016 • PubMed indexed study
PMID 27734935 from Scientific reports.
Outcome: Study design: OTHER. Quality score: 4.7/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2016 • PubMed indexed study
PMID 26764331 from The Journal of nutrition.
Outcome: Study design: OTHER. Quality score: 4.7/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2015 • PubMed indexed study
PMID 26362125 from Annals of medicine.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.6/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2005 • PubMed indexed study
PMID 16076102 from Journal of agricultural and food chemistry.
Outcome: Study design: OTHER. Quality score: 4.6/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2004 • PubMed indexed study
PMID 15157944 from The Journal of nutritional biochemistry.
Outcome: Study design: OTHER. Quality score: 4.6/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 1999 • PubMed indexed study
PMID 10228605 from Phytomedicine : international journal of phytotherapy and phytopharmacology.
Outcome: Study design: OTHER. Quality score: 4.6/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2002 • PubMed indexed study
PMID 11823573 from The Journal of nutrition.
Outcome: Study design: OTHER. Quality score: 4.6/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2006 • PubMed indexed study
PMID 17022438 from The Medical journal of Australia.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.5/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2005 • PubMed indexed study
PMID 16180802 from Ceska gynekologie.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.5/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 1997 • PubMed indexed study
PMID 9503413 from Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.5/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2016 • PubMed indexed study
PMID 26507778 from Nutrition research (New York, N.Y.).
Outcome: Study design: OTHER. Quality score: 4.4/10.[1322,1324,1365, etc.]
Open sourceANIMAL • 2023 • PubMed indexed study
PMID 36945935 from Turkish journal of medical sciences.
Outcome: Study design: ANIMAL. Quality score: 4.3/10.[1322,1324,1365, etc.]
Open sourceMECHANISTIC • 2022 • PubMed indexed study
PMID 34302129 from European journal of clinical nutrition.
Outcome: Study design: CASE_REPORT. Quality score: 4.3/10.[1322,1324,1365, etc.]
Open sourceMECHANISTIC • 2016 • PubMed indexed study
PMID 27245208 from European journal of clinical nutrition.
Outcome: Study design: CASE_REPORT. Quality score: 4.2/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2016 • PubMed indexed study
PMID 27263111 from Neuromolecular medicine.
Outcome: Study design: OTHER. Quality score: 4.1/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2017 • PubMed indexed study
PMID 28498422 from International journal of oncology.
Outcome: Study design: OTHER. Quality score: 4.1/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2015 • PubMed indexed study
PMID 26271597 from Biochemical and biophysical research communications.
Outcome: Study design: OTHER. Quality score: 4.1/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2010 • PubMed indexed study
PMID 21104925 from Biopharmaceutics & drug disposition.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2010 • PubMed indexed study
PMID 20930421 from Drug metabolism and pharmacokinetics.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2002 • PubMed indexed study
PMID 12175517 from Cancer letters.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2013 • PubMed indexed study
PMID 21838705 from Current drug metabolism.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 1996 • PubMed indexed study
PMID 8870956 from Archives of toxicology.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 1994 • PubMed indexed study
PMID 7526077 from Journal of ethnopharmacology.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2013 • PubMed indexed study
PMID 23127645 from Journal of ethnopharmacology.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2002 • PubMed indexed study
PMID 12127300 from Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1322,1324,1365, etc.]
Open sourcePUBMED • 2009 • PubMed indexed study
PMID 19643074 from Analytical biochemistry.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1322,1324,1365, etc.]
Open sourceANIMAL • 2002 • PubMed indexed study
PMID 12042427 from The Journal of nutrition.
Outcome: Study design: ANIMAL. Quality score: 3.6/10.[1322,1324,1365, etc.]
Open sourceIN_VITRO • 2010 • PubMed indexed study
PMID 20140680 from European journal of nutrition.
Outcome: Study design: IN_VITRO. Quality score: 3.1/10.[1322,1324,1365, etc.]
Open sourceIN_VITRO • 2001 • PubMed indexed study
PMID 11238822 from The Journal of nutrition.
Outcome: Study design: IN_VITRO. Quality score: 3.1/10.[1322,1324,1365, etc.]
Open sourceANIMAL • 2010 • PubMed indexed study
PMID 20610890 from Drug metabolism and pharmacokinetics.
Outcome: Study design: ANIMAL. Quality score: 3.0/10.[1322,1324,1365, etc.]
Open sourceANIMAL • 2013 • PubMed indexed study
PMID 23543654 from Indian journal of pharmacology.
Outcome: Study design: ANIMAL. Quality score: 3.0/10.[1322,1324,1365, etc.]
Open sourceANIMAL • 2000 • PubMed indexed study
PMID 10882191 from Prostaglandins, leukotrienes, and essential fatty acids.
Outcome: Study design: ANIMAL. Quality score: 3.0/10.[1322,1324,1365, etc.]
Open sourceIN_VITRO • 2025 • PubMed indexed study
PMID 40017524 from Mediators of inflammation.
Outcome: Study design: IN_VITRO. Quality score: 2.8/10.[1322,1324,1365, etc.]
Open sourceIN_VITRO • 1997 • PubMed indexed study
PMID 9121937 from Nutrition and cancer.
Outcome: Study design: IN_VITRO. Quality score: 2.5/10.[1322,1324,1365, etc.]
Open sourceIN_VITRO • 2011 • PubMed indexed study
PMID 21138349 from Journal of medicinal food.
Outcome: Study design: IN_VITRO. Quality score: 2.5/10.[1322,1324,1365, etc.]
Open source